Shaaban HE, Abdellatef A, Okasha HH. Hepatic recompensation according to Baveno VII criteria via transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2024; 30(12): 1777-1779 [PMID: 38617737 DOI: 10.3748/wjg.v30.i12.1777]
Corresponding Author of This Article
Hossam Eldin Shaaban, FACG, FASGE, MD, MSc, PhD, Doctor, Department of Internal Medicine and Gastroenterology, NHTMRI, No. 10 Kasr Alainy Street, Cairo 11796, Egypt. hsshaaban@aol.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Hossam Eldin Shaaban, Department of Internal Medicine and Gastroenterology, NHTMRI, Cairo 11796, Egypt
Abeer Abdellatef, Hussein Hassan Okasha, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kasr Al-Aini School of Medicine, Cairo University, Cairo 11562, Egypt
Author contributions: Shaaban HE, Abdellatef A, and Okasha HH, shared equally in letter writing; Okasha HH revised the letter.
Conflict-of-interest statement: The authors have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hossam Eldin Shaaban, FACG, FASGE, MD, MSc, PhD, Doctor, Department of Internal Medicine and Gastroenterology, NHTMRI, No. 10 Kasr Alainy Street, Cairo 11796, Egypt. hsshaaban@aol.com
Received: October 29, 2023 Peer-review started: October 29, 2023 First decision: December 6, 2023 Revised: December 30, 2023 Accepted: February 20, 2024 Article in press: February 20, 2024 Published online: March 28, 2024
Abstract
Transjugular intrahepatic portosystemic shunt is a therapeutic modality done through interventional radiology. It is aimed to decrease portal pressure in special situations for patients with decompensated liver disease with portal hypertension. It represents a potential addition to the therapeutic modalities that could achieve hepatic recompensation in those patients based on Baveno VII criteria.
Core Tip: Liver cirrhosis is a complication of chronic liver disease. Hepatic decompensation follows a period of compensation if the etiology of the chronic liver disease is not eliminated and the liver inflammation is persistent. Hepatic recompensation is a novel term in which decompensation reverses after the clearance of the etiological factors in some patients. The use of a transjugular intrahepatic portosystemic shunt is a potential addition to achieve recompensation in a subset of patients with portal hypertension as demonstrated in published research.
